Humana drug alerts.

Drug Recalls, Alerts, and New Therapies

This page is your source for pharmacy-related safety alerts, drug recalls, new therapies and generics, and other medication information.

Drug alerts

11/17/2011
Zyprexa® is now available as a generic.
(169 KB) Download PDF
English
11/1/2011
According to the U.S. Food and Drug Administration (FDA), Avandia (a rosiglitazone-containing product), will no longer be dispensed through your local pharmacy effective November 18, 2011.
(150 KB) Download PDF
English
10/13/2011
According to the U.S. Food and Drug Administration (FDA), using repackaged Avastin® (bevacizumab) for eye injections can cause serious eye infections in rare cases.
(32 KB) Download PDF
English
10/13/2011
According to the FDA, using the antidepressant Celexa can lead to a rare ventricular tachycardia.
(32 KB) Download PDF
English
10/13/2011
According to the FDA, using Reclast can lead to severe kidney failure in rare cases.
(32 KB) Download PDF
English
8/19/2011
According to the U.S. Food and Drug Administration (FDA), using Zyvox (linezolid) and psychiatric medications affecting serotonin levels, can cause side effects.
(26 KB) Download PDF
English
8/11/2011
Arixtra® is now available as a generic
(165 KB) Download PDF
English
8/11/2011
Tamiflu® May Cause Side Effects
(166 KB) Download PDF
English
8/11/2011
Valproate Medications May Cause Side Effects
(152 KB) Download PDF
English
7/28/2011
Possible side effects of using Erythropoiesis-Stimulating Agents
According to the FDA, using Erythropoiesis-Stimulating Agents such as Procrit®, Epogen®, or Aranesp® for the treatment of anemia in patients with chronic kidney disease can cause an increased risk of harmful side effects.
(148 KB) Download PDF
English
7/15/2011
Recall of some butalbital, acetaminophen and caffeine tablets
The manufacturer of butalbital, acetaminophen and caffeine tablets is recalling some bottles of this medicine after a single bottle of tablets was found incorrectly labeled.
(23 KB) Download PDF
English
7/15/2011
Recall of some Endocet® 10/325 mg tablets
The manufacturer of Endocet® 10/325 mg tablets is recalling some bottles of this medicine because some bottles may contain different strength tablets.
(26 KB) Download PDF
English
7/15/2011
Recall of some hydrocodone and acetaminophen tablets
The manufacturer of hydrocodone and acetaminophen tablets is recalling some bottles of this medicine after a single bottle of tablets was found incorrectly labeled.
(23 KB) Download PDF
English
7/15/2011
The FDA says Simvastatin (Zocor) 80mg may cause muscle injury.
(105 KB) Download PDF
English
6/24/2011
Ropinirole 1 mg tablets recalled
One lot of Ropinirole 1 mg tablets tablets has been recalled by its manufacturer CorePharma LLC.
(23 KB) Download PDF
English
6/24/2011
Glyburide 2.5 mg tablets recalled
One lot of Glyburide 2.5 mg tablets tablets has been recalled by its manufacturer CorePharma LLC.
(23 KB) Download PDF
English
5/20/2011
Allegra® and Allegra-D® are now available without a prescription
Allegra® (fexofenadine) and Allegra-D® (fexofenadine/pseudoephedrine) are now available over-the-counter (OTC) and may be purchased without a prescription.
(39 KB) Download PDF
English
5/20/2011
Important Recall Notice Regarding using tumor necrosis factor (TNF) blockers
According to the U.S. Food and Drug Administration (FDA), using tumor necrosis factor (TNF) blockers (medicines like Humira®, Enbrel®, Simponi®, Cimzia®, Remicade®) , azathioprine, and/or mercaptopurine can cause side effects.
(32 KB) Download PDF
English
5/20/2011
Important Recall Notice Regarding Coumadin
One lot number of Coumadin 5 mg tablets has been recalled by its manufacturer, Bristol-Myers Squibb because a single tablet was found to be higher in potency than expected.
(28 KB) Download PDF
English
4/28/2011
PPI extended usage causes unwanted side effects
According to the U.S. Food and Drug Administration (FDA), using Proton Pump Inhibitors (Nexium, Prevacid, Prilosec, etc) for an extended period of time may cause low magnesium levels.
(32 KB) Download PDF
English
4/28/2011
Xalatan now is available in generic form-latanoprost.
Xalatan®, a drug approved to help with the treatment of glaucoma, is now available as a generic, latanoprost.
(57 KB) Download PDF
English
4/15/2011
Auralgan Otic Solution Removed From The Market
The FDA notified companies that make, ship, or sell Auralgan Otic Solution to stop. This is because the medicine does not have FDA approval and its labeling does not include adequate directions. This means Auralgan Otic Solution will no longer be available.
(57 KB) Download PDF
English
01/01/11
Hydrocodone, Acetaminophen, and Phenobarbital Removed from Market
Qualitest Pharmaceuticals issued a voluntary nationwide recall of hydrocodone and acetaminophen tablets 10mg / 500mg and phenobarbital tablets 32.4 mg. An individual bottle of hydrocodone and acetaminophen tablets, 10mg / 500mg, 60 count was found incorrectly labeled with a phenobarbital tablets 32.4mg, 1000 count label.
(69 KB) Download PDF
English
12/30/10
Generic Colchicine Removed From Market
This change happened because of a ruling by the U.S. Food and Drug Administration (FDA).
(30 KB) Download PDF
English
12/30/10
Propoxyphene Removed From Market
This change happened because of a ruling by the U.S. Food and Drug Administration (FDA).
(29 KB) Download PDF
English
11/04/2010
Fentanyl Transdermal Patches Recalled by Actavis
Actavis is voluntarily recalling 18 lots of Fentanyl transdermal system 25 mcg/h.
(35 KB) Download PDF
English
10/16/2010
Important Recall Notice Regarding Methotrexate Injection
Sandoz Inc. is voluntarily recalling all 50mg/2mL and 250mg/10mL vials of Sandoz and Parenta brand Methotrexate Injection. Please read the attached for more information about this recall and further instructions.
(50 KB) Download PDF
English
10/1/2010
A generic is now availble for StratteraTM
A generic is now available for Strattera. If you currently take Strattera and choose the generic alternative, your cost may be lower. Ask your doctor or pharmacist whether Atomoxetine (generic name of brand name Strattera) would be right for you.
9/28/2010
U.S. FDA issues a warning regarding possible link between the use of ARBs and a small increased risk of cancer.
On July 15, the U.S. Food and Drug Administration (FDA) issued a warning regarding a possible link between the use of angiotensin receptor blockers (ARBs) and a small increased risk of cancer based upon a recently published meta-analysis in Lancet Oncology. ARBs have been widely used since the approval of Cozaar® (losartan) in 1995. Currently seven ARBs are available, including Atacand® (candesartan), Avapro® (irbesartan), Benicar® (olmesartan), Cozaar (losartan), Diovan® (valsartan), Micardis® (telmisartan), and Teveten® (eprosartan).If you are currently taking a ARB, the FDA believes that ARB use is of significant benefit in disease states such as hypertension and heart failure, and recommends that ARBs continue to be used as recommended per approved manufacturer labels. To date, the FDA has not concluded that ARBs increase the risk of cancer.
7/1/2010
Pfizer Inc. has announced the voluntary withdrawal from the U.S. market of the drug Mylotarg
(30 KB) Download PDF
English
3/18/2010
LifeScan is voluntarily recalling Test Strips
LifeScan is voluntarily recalling eight lots of OneTouch® SureStep® Test Strips.
(37 KB) Download PDF
English
3/4/2010
OneTouch SureStep Test Strips recalled
8 lots of OneTouch SureStep Test Strips have been recalled by their manufacturer LifeScan
(31 KB) Download PDF
English
3/2/2010
Azmacort Inhalation Aerosol discontinued
Azmacort® (triamcinolone acetonide) Inhalation Aerosol discontinued
(36 KB) Download PDF
English
2/23/2010
GlucoPro Insulin Syringes
Nipro Medical Corporation is voluntarily recalling all lots of GlucoPro® insulin syringes.
(41 KB) Download PDF
English
2/2/2010
GlucoPro®Insulin Syringes Recalled
GlucoPro Insulin Syringes Recalled by its manufacturer Nipro Medical Corporation
(45 KB) Download PDF
English
12/29/2009
Sanofi Pasteur H1N1 Pediatric Vaccine in Pre-Filled Syringes Recalled
Sanofi Pasteur has issued a non-safety related voluntarily recall of certain lots of H1N1 Pediatric (0.25 ml, for 6-35 months old) vaccine in pre-filled syringes.
(36 KB) Download PDF
English
11/3/2009
Accusure Insulin Syringes Recalled
Qualitest Pharmaceuticals, Inc. is voluntarily recalling all lots of Accusure Insulin Syringes.
(27 KB) Download PDF
English
9/2/2009
Accusure Insulin Syringes Recall
Specific lots of Accusure®Insulin Syringes have been recalled by its manufacturer Qualitest Pharmaceuticals, Inc.
(27 KB) Download PDF
English
8/20/2009
Dextroamphetamine/Amphetamine 20mg Tablets Recall
Dextroamphetamine/Amphetamine 20mg tablets have been recalled by its manufacturer Barr Laboratories
(27 KB) Download PDF
English
8/11/2009
Casodex is Now Generic
On 7/1/09 Casodex became available in generic form
(27 KB) Download PDF
English
8/4/2009
BD Luer Lok Syringes
BD Luer Lok Syringes have been recalled by its manufacturer Becton-Dickenson
(27 KB) Download PDF
English
7/30/2009
Quick-set Infusion Sets
Specific lots of Quick-Set Infusion Sets have been recalled by its manufacturer, Medtronic, Inc.
(34 KB) Download PDF
English
5/12/2009
Topamax is Now Generic
On 4/1/09 TOPAMAX became available in generic form
(300 KB) Download PDF
English
4/7/2009
Digoxin 0.125 mg and 0.25 mg Tablets
Caraco Pharmaceutical Laboratories, Ltd., voluntarily recalls all lots of Digoxin tablets due to size variability
(300 KB) Download PDF
English
3/26/2009
Propafenone 225 mg Tablets
Watson Laboratories voluntarily recalls one lot due to the potential presence of oversized tablets
(300 KB) Download PDF
English
12/23/2008
CFC-Propelled Albuterol Inhalers
CFC-Propelled Albuterol Inhalers will not be Available Starting January 1, 2009
(300 KB) Download PDF
English
12/23/2008
Multiple Medications by ETHEX Corp. Recalled
Six medications have been recalled due to the potential presence of oversized tablets
(300 KB) Download PDF
English
12/4/2008
ReliOn Insulin Syringes - Medical Device Recall
Mislabeled syringes may lead to an overdose of as much as 2.5 times the intended dose
(300 KB) Download PDF
English
10/15/2008
Dextroamphetamine Sulfate 5 mg Tablets
ETHEX Corp. voluntarily recalls three lots due to the potential presence of oversized tablets
(300 KB) Download PDF
English

Supplemental Insurance

Financial Protection

Financial Protection Plans

Humana offers life & supplemental insurance options that are affordable, simple to understand, and easy to obtain.